In Relapsed Refractory Patients With Peripheral T Cell Lymphoma clinical trials

Explore recruiting in relapsed refractory patients with peripheral t cell lymphoma clinical trials.

Recruiting in relapsed refractory patients with peripheral t cell lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

In Relapsed Refractory Patients With Peripheral T Cell Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

KILT - A RANDOMIZED NON COMPARATIVE PHASE II STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX ALONE IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA

Belgium, Spain, Germany, France

Therapeutic exploratory (Phase II) EU CTIS Study details

In Relapsed Refractory Patients With Peripheral T Cell Lymphoma trials by city

In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Toronto In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Vancouver In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Montreal In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Calgary In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Edmonton In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Ottawa In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Winnipeg In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Quebec City In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Hamilton In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Kitchener In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in London In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Halifax In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in New York In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Los Angeles In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Chicago In Relapsed Refractory Patients With Peripheral T Cell Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease